Nu Skin Relaunches Bestseller 'The Aging Myth'
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 06 2026
0mins
Should l Buy NUS?
Source: Newsfilter
- Bestseller Relaunch: Nu Skin announced the relaunch of the bestselling book 'The Aging Myth' by Dr. Joseph Chang, chair of the Scientific Advisory Board, aiming to unveil the science behind measurable biology and evidence-based longevity, marking a significant milestone in the beauty and wellness sector.
- Updated Scientific Foundation: The new edition integrates over 15 years of research, emphasizing that aging is not a genetic destiny but a dynamic biological process, which has propelled Nu Skin's innovations in the intelligent beauty and wellness platform Prysm iO™.
- Strong Market Response: The original edition quickly reached #2 on The New York Times Best Seller List in its first week and secured the top spot at Barnes & Noble and on Amazon, reflecting a high consumer interest in health and longevity themes.
- Intelligent Health Platform: The updated book expands on cellular resilience, oxidative stress management, and the role of measurable biomarkers in health optimization, showcasing how modern technology enables individuals to gain objective insights into their biological age, further solidifying Nu Skin's market leadership.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NUS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NUS
About NUS
Nu Skin Enterprises Inc. develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. It has nine segments, consisting of its seven geographic Nu Skin segments - Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan - and two Rhyz segments - Manufacturing and Rhyz Other. Its brands include Nu Skin personal care, Pharmanex nutrition and ageLOC anti-aging. Its skin and beauty solutions include acne and blemishes, anti-aging, dark circles and puffiness, discoloration, dry skin, lifting and firming, lines and wrinkles, and oily skin and pores. Its nutrition solutions include bone and joint health, brain and memory, energy and stamina, heart health, immunity support, nail skin and hair health, and women's health. It offers various beauty devices, including ageLOC Rose Gold LumiSpa iO, ageLOC LumiSpa Silicone Head, ageLOC LumiSpa iO Stand and LumiSpa Rose Gold Accent Twin Pack.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Nu Skin Launches Prysm iO Intelligent Wellness Platform
- Product Launch: Nu Skin has launched the Prysm iO intelligent nutritional wellness platform in the U.S., which provides personalized feedback on antioxidant levels through a non-invasive skin scan in just 15 seconds, empowering users to better understand how their nutrition supports overall health.
- Technological Innovation: Built on over 20 years of carotenoid research, Prysm iO utilizes patented Spectral Rai technology to capture more than 700,000 hyperspectral absorption measurements during each scan, delivering a scientifically-backed personalized 'Nutrition Health Score'.
- Clinical Validation: Recent clinical studies demonstrate a strong correlation between Prysm iO measurements and blood serum carotenoid levels (R² = 0.75-0.77), confirming its accuracy and consistency across diverse skin types, thereby enhancing user confidence in health decision-making.
- Market Positioning: Now available in the U.S. for $375, Prysm iO signifies Nu Skin's further expansion into the intelligent beauty and wellness sector, aiming to help consumers make more informed health choices through science-backed personalized insights.
See More
Thorne Brand Experiences Rapid Growth Driven by Gen Z
- Revenue Expectations: Thorne is projected to reach $650 million in annual revenue for 2023, driven by the health-conscious focus of Gen Z and millennial consumers, indicating strong appeal in the younger market segment.
- Consumer Growth: The number of direct consumers has surged from 4 million at the end of 2023 to 7 million, fueling a 63% increase in direct sales, demonstrating the brand's expanding influence among younger shoppers.
- Market Trends: The U.S. vitamins and supplements market is expected to reach $125 billion by 2025, with an 11% growth projected by 2027, reflecting a shift towards proactive health management and demand for personalized products among younger consumers.
- Subscription Model: Thorne attracts consumers to subscribe by offering free shipping and a 10% discount on each refill, with about 50% of shoppers under 40 opting for subscriptions despite some hesitation, showcasing the brand's competitive edge in pricing and service.
See More
Nu Skin Appoints Chelsea Lantz as Interim CFO Following Departure of James Thomas
- Executive Change: Nu Skin announced the appointment of Chelsea Lantz as interim CFO, effective immediately following the departure of James Thomas, who left after 16 years with the company to pursue other opportunities, highlighting challenges in executive stability.
- Internal Promotion: Lantz, who joined the company in 2011 and has served as corporate controller since 2023, will take on the interim CFO role, which is expected to support the company's ongoing efforts in operational and balance sheet improvements.
- Formal Search Initiated: Nu Skin has begun a formal search for a permanent CFO, indicating the company's commitment to restructuring its executive team and long-term strategic planning, aiming to ensure continuity and stability in financial management.
- Market Reaction: Following this announcement, Nu Skin's stock price fell 0.14% in after-hours trading to $7.12, reflecting market caution regarding the executive change and potentially impacting investor confidence in the company's future performance.
See More
Nu Skin Appoints Chelsea Lantz as Interim CFO
- Executive Transition: Nu Skin announced the appointment of Chelsea Lantz as interim Chief Financial Officer, effective immediately following James Thomas's resignation, demonstrating the company's agility in executive changes.
- Financial Leadership Experience: Lantz has been with Nu Skin since 2011 and has served as corporate controller since 2023, leading cost improvement initiatives that resulted in a significant year-over-year increase in EPS, showcasing her strong financial management background.
- Strategic Transformation: CEO Ryan Napierski stated that Lantz's appointment will drive the company's transformation into a leading intelligent beauty and wellness platform, emphasizing ongoing efforts to enhance operational performance and strengthen the balance sheet.
- Succession Planning Initiated: Nu Skin's board has initiated a formal process to appoint a permanent CFO, reflecting the company's commitment to executive stability and proactive planning for future growth.
See More
Nu Skin Appoints New COO to Drive Growth
- Executive Appointment: Nu Skin Enterprises has appointed Chayce Clark as Chief Operating Officer effective immediately, while he continues to serve as Chief Legal Officer, reflecting the company's confidence in its leadership team and operational strategy.
- Growth Opportunities: The company highlighted growth potential from the Prysm iO intelligent wellness platform and plans to place 100,000 devices in India by 2026, indicating a strategic focus on emerging markets for expansion.
- Career Development: Prior to this promotion, Clark served as Vice President, Deputy General Counsel, and General Counsel, and his extensive legal and management experience is expected to enhance the company's operational efficiency and strategic execution.
- Long-Term Turnaround Potential: While the market remains cautious about Nu Skin's long-term transformation, the company demonstrates potential in new product offerings and market expansion, particularly with its initiatives in India expected to drive future growth.
See More
Pinterest Misses Q4 Revenue Expectations
- Revenue Shortfall: Pinterest reported Q4 revenue of $1.32 billion, falling short of analyst expectations of $1.33 billion, indicating competitive pressures that may undermine future investor confidence.
- Earnings Miss: The company posted adjusted earnings of 67 cents per share, below the anticipated 69 cents, reflecting challenges in profitability that could lead to shareholder scrutiny of management.
- Significant Stock Decline: Pinterest shares plummeted 19.5% to $14.95 in pre-market trading, a drastic move that may raise concerns about the company's future performance and influence investor decisions.
- Mixed Market Sentiment: U.S. stock futures showed mixed results, with Dow futures down about 0.2%, reflecting cautious market sentiment potentially linked to Pinterest's earnings report, further exacerbating investor unease.
See More
Nu Skin Launches Prysm iO Intelligent Wellness Platform
- Product Launch: Nu Skin has launched the Prysm iO intelligent nutritional wellness platform in the U.S., which provides personalized feedback on antioxidant levels through a non-invasive skin scan in just 15 seconds, empowering users to better understand how their nutrition supports overall health.
- Technological Innovation: Built on over 20 years of carotenoid research, Prysm iO utilizes patented Spectral Rai technology to capture more than 700,000 hyperspectral absorption measurements during each scan, delivering a scientifically-backed personalized 'Nutrition Health Score'.
- Clinical Validation: Recent clinical studies demonstrate a strong correlation between Prysm iO measurements and blood serum carotenoid levels (R² = 0.75-0.77), confirming its accuracy and consistency across diverse skin types, thereby enhancing user confidence in health decision-making.
- Market Positioning: Now available in the U.S. for $375, Prysm iO signifies Nu Skin's further expansion into the intelligent beauty and wellness sector, aiming to help consumers make more informed health choices through science-backed personalized insights.
See More
Thorne Brand Experiences Rapid Growth Driven by Gen Z
- Revenue Expectations: Thorne is projected to reach $650 million in annual revenue for 2023, driven by the health-conscious focus of Gen Z and millennial consumers, indicating strong appeal in the younger market segment.
- Consumer Growth: The number of direct consumers has surged from 4 million at the end of 2023 to 7 million, fueling a 63% increase in direct sales, demonstrating the brand's expanding influence among younger shoppers.
- Market Trends: The U.S. vitamins and supplements market is expected to reach $125 billion by 2025, with an 11% growth projected by 2027, reflecting a shift towards proactive health management and demand for personalized products among younger consumers.
- Subscription Model: Thorne attracts consumers to subscribe by offering free shipping and a 10% discount on each refill, with about 50% of shoppers under 40 opting for subscriptions despite some hesitation, showcasing the brand's competitive edge in pricing and service.
See More
Nu Skin Appoints Chelsea Lantz as Interim CFO Following Departure of James Thomas
- Executive Change: Nu Skin announced the appointment of Chelsea Lantz as interim CFO, effective immediately following the departure of James Thomas, who left after 16 years with the company to pursue other opportunities, highlighting challenges in executive stability.
- Internal Promotion: Lantz, who joined the company in 2011 and has served as corporate controller since 2023, will take on the interim CFO role, which is expected to support the company's ongoing efforts in operational and balance sheet improvements.
- Formal Search Initiated: Nu Skin has begun a formal search for a permanent CFO, indicating the company's commitment to restructuring its executive team and long-term strategic planning, aiming to ensure continuity and stability in financial management.
- Market Reaction: Following this announcement, Nu Skin's stock price fell 0.14% in after-hours trading to $7.12, reflecting market caution regarding the executive change and potentially impacting investor confidence in the company's future performance.
See More
Nu Skin Appoints Chelsea Lantz as Interim CFO
- Executive Transition: Nu Skin announced the appointment of Chelsea Lantz as interim Chief Financial Officer, effective immediately following James Thomas's resignation, demonstrating the company's agility in executive changes.
- Financial Leadership Experience: Lantz has been with Nu Skin since 2011 and has served as corporate controller since 2023, leading cost improvement initiatives that resulted in a significant year-over-year increase in EPS, showcasing her strong financial management background.
- Strategic Transformation: CEO Ryan Napierski stated that Lantz's appointment will drive the company's transformation into a leading intelligent beauty and wellness platform, emphasizing ongoing efforts to enhance operational performance and strengthen the balance sheet.
- Succession Planning Initiated: Nu Skin's board has initiated a formal process to appoint a permanent CFO, reflecting the company's commitment to executive stability and proactive planning for future growth.
See More
Nu Skin Appoints New COO to Drive Growth
- Executive Appointment: Nu Skin Enterprises has appointed Chayce Clark as Chief Operating Officer effective immediately, while he continues to serve as Chief Legal Officer, reflecting the company's confidence in its leadership team and operational strategy.
- Growth Opportunities: The company highlighted growth potential from the Prysm iO intelligent wellness platform and plans to place 100,000 devices in India by 2026, indicating a strategic focus on emerging markets for expansion.
- Career Development: Prior to this promotion, Clark served as Vice President, Deputy General Counsel, and General Counsel, and his extensive legal and management experience is expected to enhance the company's operational efficiency and strategic execution.
- Long-Term Turnaround Potential: While the market remains cautious about Nu Skin's long-term transformation, the company demonstrates potential in new product offerings and market expansion, particularly with its initiatives in India expected to drive future growth.
See More
Pinterest Misses Q4 Revenue Expectations
- Revenue Shortfall: Pinterest reported Q4 revenue of $1.32 billion, falling short of analyst expectations of $1.33 billion, indicating competitive pressures that may undermine future investor confidence.
- Earnings Miss: The company posted adjusted earnings of 67 cents per share, below the anticipated 69 cents, reflecting challenges in profitability that could lead to shareholder scrutiny of management.
- Significant Stock Decline: Pinterest shares plummeted 19.5% to $14.95 in pre-market trading, a drastic move that may raise concerns about the company's future performance and influence investor decisions.
- Mixed Market Sentiment: U.S. stock futures showed mixed results, with Dow futures down about 0.2%, reflecting cautious market sentiment potentially linked to Pinterest's earnings report, further exacerbating investor unease.
See More
